title: Clinical inquiries. When should you treat scabies empirically?
authors.affiliation: Oregon Health and Sciences University, Portland, USA.
authors.forename: Tanya L
authors.initials: TL
authors.lastname: Page
authors.forename: M Patrice
authors.initials: MP
authors.lastname: Eiff
authors.forename: Dolores Zegar
authors.initials: DZ
authors.lastname: Judkins
authors.forename: Barbara
authors.initials: B
authors.lastname: Walker
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D001556:Hexachlorocyclohexane / Q000627:therapeutic use; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D007306:Insecticides; D007559:Ivermectin / Q000627:therapeutic use; D026023:Permethrin / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology; D012520:Sarcoptes scabiei; D012532:Scabies / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission
chemical_list: D000977:Antiparasitic Agents; D007306:Insecticides; D026023:Permethrin; D001556:Hexachlorocyclohexane; D007559:Ivermectin